Clinical Trial Detail

NCT ID NCT04145375
Title Continuation Protocol for ZEN003694 in Patients Experiencing Clinical Benefit While Enrolled in a ZEN003694 Protocol
Recruitment Enrolling by invitation
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Zenith Epigenetics
Indications

prostate cancer

Therapies

Enzalutamide + ZEN-3694

Age Groups: adult senior

No variant requirements are available.